Condition: Preeclampsia · Preeclampsia (PE) · Preeclampsia (PE) Risk · Sponsor: University of Tennessee Graduate School of Medicine
This study's primary purpose is to determine the relationship between aspirin metabolism and markers of metabolic dysfunction among patients at risk for preeclampsia.
This description comes directly from the study's public registry record.
Jill M Maples, PhD · 865-305-9367 · jmaples1@utmck.edu
Always discuss trial participation with your own doctor first.
| University of Tennessee Medical Center | Knoxville, Tennessee, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06802861